These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12888073)

  • 1. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
    Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
    Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M; Finger PT
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
    Chalasani R; Giblin M; Conway RM
    Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical Mitomycin C as a therapy of conjunctival tumours].
    Schallenberg M; Niederdräing N; Steuhl KP; Meller D
    Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C; Lommatzsch PK
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J; Frucht-Pery J
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
    Rodríguez-Ares T; Touriño R; De Rojas V; Becerra E; Capeans C
    Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
    Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    Khong JJ; Muecke J
    Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
    Mazzini C; Pieretti G; Vicini G; Nicolosi C; Virgili G; Giansanti F
    Eur J Ophthalmol; 2021 Nov; 31(6):NP71-NP74. PubMed ID: 32674607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
    Cartsburg O; Kallen C; Hillenkamp J; Sundmacher R; Pomjanski N; Böcking A
    Anal Cell Pathol; 2001; 23(2):65-74. PubMed ID: 11904462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
    Colby KA; Nagel DS
    Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.